Corrigendum to “Bromelain inhibits COX-2 expression by blocking the activation of MAPK regulated NF-kappa B against skin tumor-initiation triggering mitochondrial death pathway” [Canc. Lett. (2009) 282(2) 167–76 doi:10.1016/j.canlet.2009.03.003] (Cancer Letters (2009) 282(2) (167–176), (S0304383509001773), (10.1016/j.canlet.2009.03.003));Bromelain inhibits COX-2 expression by blocking the activation of MAPK regulated NF-kappa B against skin tumor-initiation triggering mitochondrial death pathway

Cancer Letters

Volumn 282, Issue 2, 2009, Pages 167-176

  Bhui, Kulpreet ^a   Prasad, Sahdeo ^a   George, Jasmine ^a   Shukla, Yogeshwer ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

Author keywords

Apoptosis; Bromelain; Chemoprevention; DNA alkaline unwinding; DNA damage; Mouse skin

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BROMELAIN; CASPASE 3; CASPASE 9; CYCLOOXYGENASE 2; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER STAGING; CELL DEATH; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA DAMAGE; DNA NICK TRANSLATION; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; MODULATION; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SKIN CARCINOGENESIS; SKIN TUMOR; TUMOR VOLUME; UPREGULATION;

ANANAS; ANANAS COMOSUS;

EID: 67649968417     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2020.01.017     Document Type: Erratum

References (37)

1. Tompa A. Theory and practice of primary cancer prevention. Magy. Onkol. 51 (2007) 7-21
2. De Marzo A.M., Platz E.A., Sutcliffe S., Xu J., Grönberg H., Drake C.G., Nakai Y., Isaacs W.B., and Nelson W.G. Inflammation in prostate carcinogenesis. Nat. Rev. Cancer 7 (2007) 256-269
3. Russo G.L. Ins and outs of dietary phytochemicals in cancer chemoprevention. Biochem. Pharmacol. 74 (2007) 533-544
4. Hale L.P. Proteolytic activity and immunogenicity of oral bromelain within the gastrointestinal tract of mice. Int. Immunopharmacol. 4 (2004) 255-264
5. Sarkar F.H., and Li Y. Cell signaling pathways altered by natural chemopreventive agents. Mutat. Res. 555 (2004) 53-64
6. Taussig S.J., Szekerczes J., and Batkin S. Inhibition of tumor growth in vitro by bromelain, an extract of the pineapple plant (Ananas cosmosus). Planta Med. 6 (1985) 538-539
7. Kalra N., Bhui K., Roy P., Srivastava S., George J., Prasad S., and Shukla Y. Regulation of p53, nuclear factor kappa B and cyclooxygenase-2 expression by bromelain through targeting mitogen-activated protein kinase pathway in mouse skin. Toxicol. Appl. Pharmacol. 226 (2008) 30-37
8. Singh A., and Shukla Y. Antitumor activity of diallyl sulfide in two-stage mouse skin model of carcinogenesis. Biomed. Environ. Sci. 11 (1998) 258-263
9. Arora A., and Shukla Y. Induction of apoptosis by diallyl sulfide in DMBA induced mouse skin tumors. Nutr. Cancer 44 (2002) 89-94
10. Serpi R., Piispala J., Jarvilehto M., and Vahakangas K. Thapsigargin has similar effect on p53 protein response to benzo(a)pyrene DNA adducts as TPA in mouse skin. Carcinogenesis 20 (1999) 1755-1760
11. Arora A., Siddiqui I.A., and Shukla Y. Modulation of p53 in 7,12-dimethylbenz[a]anthracene-induced skin tumors by diallyl sulfide in Swiss albino mice. Mol. Cancer Ther. 11 (2004) 459-466
12. Lowry O.H., Rosenbrough N.K., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
13. Khan T.H., Prasad L., Sultana A., and Sultana S. Soy isoflavones inhibits the genotoxicity of benzo(a)pyrene in Swiss albino mice. Hum. Exp. Toxicol. 24 (2005) 149-155
14. Nigam N., Prasad S., and Shukla S. Preventive effects of lupeol on DMBA induced DNA alkylation damage in mouse skin. Food Chem. Toxicol. 45 (2007) 2331-2335
15. Zhang Y.H., Peng H.Y., Xia G.H., Wang M.Y., and Han Y. Anticancer effect of two diterpenoid compounds isolated from Annona glabra Linn. Acta Pharmacol. Sin. 25 (2004) 937-942
16. Nihal M., Ahmad N., Mukhtar H., and Wood G.S. Anti-proliferative and proapoptotic effects of (-)-epigallocatechin-3-gallate on human melanoma: possible implications for the chemoprevention of melanoma. Int. J. Cancer 114 (2005) 513-521
17. Philchenkov A. Caspases: potential targets for regulating cell death. J. Cell Mol. Med. 8 (2004) 432-444
18. Li Q., Withoff S., and Verma I.M. Inflammation-associated cancer: NF-κB is the lynchpin. Trends Immunol. 26 (2006) 318-325
19. Kosaka T., Miyata A., Ihara H., Hara S., Sugimoto T., Takeda O., Takahashi E., and Tanabe T. Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2. Eur. J. Biochem. 221 (1994) 889-897
20. Fletcher B.S., Kujubu D.A., Perrin D.M., and Herschman H.R. Structure of the mitogen-inducible TIS10 gene and demonstration that the TIS10-encoded protein is a functional prostaglandin G/H synthase. J. Biol. Chem. 267 (1992) 4338-4344
21. Takano T., Cybulsky A.V., Yang X., and Aoudjit L. Complement C5b-9 induces cyclooxygenase-2 gene transcription in glomerular epithelial cells. Am. J. Physiol-Renal. 281 (2001) F841-850
22. Kundu J.K., Shin Y.K., and Surh Y.J. Resveratrol modulates phorbol ester-induced pro-inflammatory signal transduction pathways in mouse skin in vivo: NF-κB and AP-1 as prime targets. Biochem. Pharmacol. 72 (2006) 1506-1515
23. Hwang D.M., Kundu J.K., Shin J.W., Lee H.J., and Surh Y.J. cis-9,trans-11-Conjugated linoleic acid down-regulates phorbol ester-induced NF-κB activation and subsequent Cox-2 expression in hairless mouse skin by targeting IκB kinase and PI3K-Akt. Carcinogenesis 28 (2007) 363-371
24. Beuth J., and Braun J.M. Modulation of murine tumor growth and colonization by bromelain an extract of the pineapple plant (Ananas comosum L.). In Vivo 19 (2005) 483-485
25. Báez R., Lopes M.T., Salas C.E., and Hernández M. In vivo antitumoral activity of stem pineapple (Ananas comosus) Bromelain. Planta. Med. 73 (2007) 1377-1383
26. Bukhari M.H., Salaria S.M., Niaz Z., Muzzafar A., Batool Z., Qureshi G.R., Naveed I.A., and Chaudhry N.A. Mutation of p53 in skin papilloma and tubular breast adenoma of albino mice. J. Coll. Physicians Surg. Pak. 16 (2006) 280-283
27. Oltersdorf T., Elmore S.W., Shoemaker A.R., Armstrong R.C., Augeri D.J., Belli B.A., Bruncko M., Deckwerth T.L., Dinges J., Hajduk P.J., Joseph M.K., Kitada S., Korsmeyer S.J., Kunzer A.R., Letai A., Li C., Mitten M.J., Nettesheim D.G., Ng S., Nimmer P.M., O'Connor J.M., Oleksijew A., Petros A.M., Reed J.C., Shen W., Tahir S.K., Thompson C.B., Tomaselli K.J., Wang B., Wendt M.D., Zhang H., Fesik S.W., and Rosenberg S.H. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435 (2005) 677-681
28. Condeelis J., and Pollard J.W. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124 (2006) 263-266
29. Lewis C.E., and Pollard J.W. Distinct role of macrophages in different tumor microenvironments. Cancer Res. 66 (2006) 605-612
30. Lai C.S., Li S., Chai C.Y., Lo C.Y., Ho C.T., Wang Y.J., and Pan M.H. Inhibitory effect of citrus 5-hydroxy-3,6,7,8,3′,4′-hexamethoxyflavone on 12-O-tetradecanoylphorbol 13-acetate-induced skin inflammation and tumor promotion in mice. Carcinogenesis 28 (2007) 2581-2588
31. Demicco E.G., Kavanagh K.T., Romieu-Mourez R., Wang X., Shin S.R., Landesman-Bollag E., Seldin D.C., and Sonenshein G.E. RelB/p52 NF-kappa B complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor I kappa B-alpha expression and promote carcinogenesis of the mammary gland. Mol. Cell Biol. 25 (2005) 10136-10147
32. Sovak M.A., Bellas R.E., Kim D.W., Zanieski G.J., Rogers A.E., Traish A.M., and Sonenshein G.E. Aberrant nuclear factor-kappa B/Rel expression and the pathogenesis of breast cancer. J. Clin. Invest. 100 (1997) 2952-2960
33. Nakshatri H., Bhat-Nakshatri P., Martin D.A., Goulet Jr. R.J., and Sledge Jr. G.W. Constitutive activation of NF-kappa B during progression of breast cancer to hormoneindependent growth. Mol. Cell Biol. 17 (1997) 3629-3639
34. Kim D.W., Sovak M.A., Zanieski G., Nonet G., Romieu-Mourez R., Lau A.W., Hafer L.J., Yaswen P., Stampfer M., Rogers A.E., Russo J., and Sonenshein G.E. Activation of NF-kappa B/Rel occurs early during neoplastic transformation of mammary cells. Carcinogenesis 21 (2000) 871-879
35. Cho Y.J., Kim J.Y., Jeong S.W., Lee S.B., and Kim O.N. Cyclic AMP induces activation of extracellular signal regulated kinases in HL-60 cells: role in cAMP-induced differentiation. Leuk. Res. 27 (2003) 51-56
36. Li D., Wu L.J., Tashiro S., Onodera S., and Ikejima T. Oridonin-induced A431 cell apoptosis partially through blockage of the Ras/Raf/ERK signal pathway. J. Pharmacol. Sci. 103 (2007) 56-66
37. Manson M.M., Gescher A., Hudson E.A., Plummer S.M., Squires M.S., and Prigent S.A. Blocking and suppressing mechanisms of chemoprevention by dietary constituents. Toxicol. Lett. 112 (2000) 499-505